COMPOUND HAVING ENHANCING ACTIVITY FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIONS
申请人:AJINOMOTO CO., INC.
公开号:US20190022039A1
公开(公告)日:2019-01-24
Compounds represented by formula (I):
wherein each symbol is as defined in the present specification, or a salt thereof are useful for the prophylaxis or treatment of diabetes and obesity, and diseases related thereto.